Wenrui Yang

Peking Union Medical College
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Journal: Scientific reports

Published: June 03, 2026

RaSizeNet: An interpretable multimodal deep learning model integrating SERS spectra and inertial microfluidic size distribution for precise detection of complex pathogens.

RaSizeNet: An interpretable multimodal deep learning model integrating SERS spectra and inertial microfluidic size distribution for precise detection of complex pathogens.

Journal: Journal of hazardous materials

Published: November 17, 2025

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy.

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy.

Journal: Annals of hematology

Published: September 03, 2025

Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overload.

Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overload.

Journal: HemaSphere

Published: July 30, 2025

Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China.

Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 06, 2025

The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia.

The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia.

Journal: Annals of hematology

Published: December 29, 2024

Comparison of Hetrombopag and Eltrombopag Added to First-Line Immunosuppressive Therapy in Severe Aplastic Anemia.

Comparison of Hetrombopag and Eltrombopag Added to First-Line Immunosuppressive Therapy in Severe Aplastic Anemia.

Journal: European journal of haematology

Published: November 05, 2024

Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia.

Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia.

Journal: Experimental hematology

Published: August 21, 2024

Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia.

Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia.

Journal: Blood cancer journal

Published: January 02, 2024

A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses.

A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses.

Journal: Annals of hematology

Published: December 05, 2023

Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia.

Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia.

Journal: Frontiers in immunology

Published: February 27, 2023

Genotype-degree of hemolysis correlation in hereditary spherocytosis.

Genotype-degree of hemolysis correlation in hereditary spherocytosis.

Journal: BMC genomics

Published: February 18, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026